#APLAR22

Program

APLAR 2022 is here!

Important note: If you are registered to attend – please be sure to login and use the virtual platform for the latest and most up to date program details. 

The APLAR 2022 official program is scheduled in the Hong Kong time zone (GMT+8). To check the program times in your location, use our time zone converter

Key

Acronyms
F.E Asia – Far East Asia
S.E Asia – South East Asia
UK – United Kingdom

0900-1000
REGISTRATION
1000-1200
MSUS Workshop Day 1

Workshop will commence at 0915 hours


History, physics, settings and knobology of MSUS: limitations of MSUS including artefacts and pitfalls
Peter Cheung (S.E Asia)

Sonoanatomy of normal musculoskeletal tissue; basic MSUS abnormalities, OMERACT definition and appearance
Priscilla Wong (F.E Asia)

Standardised scan: wrist & elbow, basic pathology (with live demo)
Carmen Ho (F.E Asia)

PRACTICAL: setting up/normal structures, handling of problems, machine settings, standardised scan: wrist/elbow

Standardised scan: knees (with live demo)
Gavin Lee (F.E Asia)
MRI workshop for axial SpA Day 1

Brought to you by UCB

Introduction of MRI in axial SpA
Shirley Chan (F.E Asia)

Imaging in SpA: back to basics
Shirley Chan (F.E Asia)

1040 - 1100 hours: break for MRI workshop attendees

Basic of spine MRI
Vince Lau (F.E Asia)

Basic of SI MRI
Victor Lee (F.E Asia)

1200-1245
LUNCH BREAK
1245-1445
MSUS Workshop Day 1 Cont.

PRACTICAL: knees

Standardised scan: shoulder & basic pathology (with live demo)
Ingrid Moller (Europe)

PRACTICAL: shoulder
MRI workshop for axial SpA Day 1 Cont.

Spine MRI inflammation
Vince Lau (F.E Asia)

SI MRI inflammation
Victor Lee (F.E Asia)

Spinal MRI lesions in axial SpA
Ho Yin Chung (F.E Asia)

Mimicking conditions
Mitsumasa Kishimoto (F.E Asia)

Artificial intelligence in magnetic resonance imaging in axial spondyloarthritis
Ho Yin Chung (F.E Asia)
1445-1515
COFFEE BREAK
1515-1700
MSUS Workshop Day 1 Cont.

Standardised scan: ankle/foot basic pathology (with demo)
Peter Mandl (Europe)

PRACTICAL: ankle/foot

Closing remarks
Carmen Ho (F.E Asia)


Workshop tutors
Carrel Yu Ka Lung
Chi Hung To
Patrick Lee
Julia Chan Pui Shan
Ng Sin Ngai Ray
Bill Lo
Stella Wong Pui Yan
Catherine Yuen Ka Yan
Clara Law Mei Yan
Yin Cheuk Wan
MRI workshop for axial SpA Day 1 Cont.

Hands on workshop - SI joint MRI interpretation

Tutors will guide participants through MRI reading and interpretation

Key

Acronyms
F.E Asia – Far East Asia
S.E Asia – South East Asia
UK – United Kingdom

0830-0900
REGISTRATION
0900-1000
MSUS Workshop Day 2

Ultrasound of the salivary glands
Ingrid Moller (Europe)

Live demonstration
Ingrid Moller (Europe)

Crystal arthropathy
Annamaria Iagnocco (Europe)

Live demonstration
Annamaria Iagnocco (Europe)

1050 - 1100 - BREAK FOR ATTENDEES
MRI workshop for axial SpA Day 2

Brought to you by UCB

Hands on workshop - spine MRI interpretation

Tutors will guide participants through MRI reading and interpretation

GRAPPA Symposium

Brought to you by UCB

Available in-person and online

Chair: Peter Nash (Oceania)

Introduction and update from GRAPPA
Peter Nash (Oceania) and Philip Mease

Year in review - clinical science
Alexis Ogdie (Americas)

Abstract presentations by Jacqueline So

Utilities of low-dose computed tomography (LDCT) on identifying patient with axial psoriatic arthritis (AxPsA) – a cross-sectional study
Author: Isaac Tsz Ho Cheng


Panel discussion

Rheumatology Health Professionals Workshop

Available online only

Predictors for knee osteoarthritis
Amy Fu
Capillaroscopy course

Introduction
Grace Ho

Anatomy of microcirculation and basic principle of capillaroscopy
Kai-Yu Ma

Application of capillaroscopy in Raynaud's phenomenon and rheumatic diseases
Andrea Low

Performing capillaroscopy
Kai-Yiu Ma

Q&A
1000 -1030
COFFEE BREAK
1030 -1200
MSUS Workshop Day 2 Cont.

Five most interesting pathologies in extremities
Peter Mandl (Europe)

Live demonstration
Peter Mandl (Europe)

Hands on workshop
All faculty

Closing remarks
Carmen Ho (F.E Asia)
MRI workshop for axial SpA Day 2 Cont.

Hands on workshop - Spine MRI interpretation

Tutors will guide participants through MRI reading and interpretation
GRAPPA Symposium
Cont.


Chair: James Wei (F.E Asia) and Katy Leung

Contribution and challenges of engaging patient in patient care and research: a psoriatic arthritis case
Jeffrey Chau (F.E Asia)

Year in review - new treatment
Muhammad Haroon

Abstract presentations by Jenny Shi

Are we treating-to-target in spondyloarthritis(SpA)? A cross sectional analysis from the Asia Pacific League of Associations for Rheumatology(APLAR) SpA Registry
Author: Isaac Tsz Ho Cheng

Association of Baseline Characteristics with Minimal Disease Activity of Guselkumab Treatment in Biologic-Experienced PsA Patients: Phase IIIb COSMOS Clinical Trial
Author: Masaru Kato


Panel discussion
Rheumatology Health Professionals Workshop Cont.

The state of the art development in technology based detection of knee osteoarthritis
Amy Fu (F.E Asia)

Self-management concepts of hip and knee osteoarthritis
Thorlene Egerton (Oceania)
Capillaroscopy course Cont.

Interpretation of capillaroscopy findings
Andrea Low

Capillaroscopy in systemic sclerosis
Kai-Yiu Ma

Reporting capillaroscopy findings
Kai-Yiu Ma

Q&A
1200 -1245
LUNCH BREAK
1245 -1400
MRI workshop for axial SpA Day 2 Cont.

Hands on workshop - mimicking conditions

Tutors will guide participants through MRI reading and interpretation
GRAPPA Symposium
Cont.


Chair: Mitsumasa Kishimoto (F.E Asia)

Axial PsA - where are we now?
Denis Poddubnyy

Abstract presentations by Satoshi Kawaai

Bimekizumab in Patients with Active Psoriatic Arthritis and an Inadequate Response to TNF Inhibitors: BE COMPLETE 16-Week Efficacy and Safety
Author: Yoshiya Tanaka


Panel discussion

Closing remarks
Rheumatology Health Professionals Workshop Cont.

Application, indications and limitations of technology-based self-management on hip and knee osteoarthritis
Kim Bennell (Oceania)
Capillaroscopy course Cont.

Case scenario
Grace Ho

Interactive slideshow quiz facilitator
MH Leung

Interactive slideshow quiz
Andrea Low

Hands-on practice
Kai-Yiu Ma
Winnie Yeung
Grace Ho

Conclusion
Grace Ho
1700-1810
Opening Ceremony
1810-1930
Welcome Reception and Official Opening of Exhibition Hall
2000-2115
Genetics and resources: impact on outcome of childhood rheumatic diseases session 1

**This is a virtual only session - all attendees are required to join this session virtually**


Chairpersons: Winnie Chan and Shahana Rahman


Paediatric rheumatology in the APLAR region: an update
Sumaira Farman (South Asia)

Familial clustering of childhood rheumatic diseases
Sulaiman Al-Mayouf (Middle East)

Monogenic lupus: phenotypes and genotypes
Nasim Movahhedi (Middle East)

Autoinglammatory syndromes: clinical diagnosis & management
Takako Miyamae (F.E Asia)

Q&A

Closing
Sumaira Farman (South Asia)
APLAR guidelines for management of SLE

**This is a virtual only session - all attendees are required to join this session virtually**


Chairpersons: Yoshiya Tanaka and CC Mok


Guideline for the management of lupus nephritis
CC Mok (F.E Asia)

Guideline for infectious diseases in SLE
Kenji Oku (F.E Asia)

Update on mangement of COVID-19 infection and vaccination in Systemic Lupus Erythematosus
Laniyati Hamijoyo (S.E Asia)

Q&A
Digital health special interest group symposium

**This is a virtual only session - all attendees are required to join this session virtually**


Chairpersons: Rebecca Grainger and Sakir Ahmed


Digital health and telemedicine in rheumatology - a new APLAR SIG
Rebecca Grainger(Oceania)

Chatbots in Singapore - screening and triaging: use of a chatbot for screening of rheumatic conditions in a multi-ethnic Asian population
Anindita Santosa (S.E Asia)

Telemedicine in SLE patients
Ho So (F.E Asia)

Role of patient self-photography in remote rheumatologic care
Lisa Traboco (S.E Asia)

What's next in digital health and telemedicine - for APLAR and you
Sakir Ahmed (South Asia)

Q&A

Key

Acronyms
F.E Asia – Far East Asia
S.E Asia – South East Asia
UK – United Kingdom

0800-0900
Psoriatic arthritis - what is new?

Chairpersons: Tin Lok Lai and Howe Hwee Siew

Does psoriasis treatment affect PsA development
Alexis Ogdie (Americas)

Peripheral spondyloarthritis and psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study
Mitsumasa Kishimoto (F.E Asia)

Q&A
Abstract session

Chairpersons: Yvonne Ho

Long-term Safety and Efficacy of Voclosporin in Asian Patients with Lupus Nephritis
Tatsuya Atsumi

Withdrawal of Maintenance Glucocorticoid versus other Immunosuppressants among patients with SLE in Long-term Clinical Remission:Non-inferiority Randomised Controlled Trial– Interim Analysis
Chengappa Kavadichanda

Enpatoran: Preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with systemic and/or cutaneous lupus erythematosus
Eric Morand

Clinical efficacy and safety of low-dose IL-2 treatment in patients with systemic lupus erythematosus
Qin-Yi Su

Combined Model of Renal Histopathology and Clinical Parameters better predicts one-year Renal Outcomes in Lupus Nephritis:Analysis of 334 Kidney Biopsies
Chengappa Kavadichanda
Abstract session

Chairpersons: Lie Dai and Samina Ghaznavi

Risk factors for major cardiovascular events in inflammatory arthritis: a time-dependent analysis on inflammatory burden, use of NSAIDs and steroid
Huan Meng

The MMP degraded and citrullinated vimentin (VICM) is a diagnostic and treatment response biomarker
Anne-Christine Bay-jensen

The effects of multigrain supplementation on nutritional indices in moderate to severe rheumatoid arthritis patients: a randomized human intervention trial
Lai Kuan Lee

Bimekizumab in Patients with Active Psoriatic Arthritis and an Inadequate Response to TNF Inhibitors: BE COMPLETE 16-Week Efficacy and Safety
Yoshiya Tanaka

Safety of the JAK inhibitors in comparison with the TNF inhibitors in RA:real world data from the HK Biologics Registry
Chi Chiu Mok

Application and simplification of the global pain assessment scale in patients with rheumatoid arthritis
Biyu Shen

A diagnostic model congstructed based on the reduced CD8+T Cell in rheumatoid arthritis
Sheng-Xiao Zhang

Vascular effect of treat to target in early rheumatoid arthritis patients - a 5uyear prospective study
Huan Meng
0900-1030
Plenary session 1

Chairpersons: Tsutomu Takeuchi and Chak-Sing Lau

Measurement challenges in SLE clinical trials
Eric Morand (Oceania)

Treatment of refractory SLE by CD19 CAR T cells
Georg Schett (Europe)

Advances in biomarkers of vasculitic diseases
Debashish Danda (South Asia)
1030-1055
BREAK AND POSTER VIEWING
1055-1200
Morning symposium 1
Morning symposium 2
Morning symposium 3
Morning symposium 4
1200-1315
COVID-19: Lessons and future directions

Chairpersons: Yukai Wang and Rohini Handa

What has the COVID-19 global rheumatology alliance taught us?
Philip Robinson (Oceania)

COVID-19 vaccines and vaccination
Chak Sing Lau (F.E Asia)

Long COVID - symptoms and mechanisms
Bin Cao (F.E Asia)

Q&A
ACR session

Chairpersons: Yoshiya Tanaka and Doug White

RA/Basic Science
Dana Orange (Americas)

Glucocorticoids in Rheumatic Diseases - The Good, The Bad, The Bone
Kenneth Saag (Americas)

Q&A
Progress in small and medium vessel vasculitis - what rheumatologists should know

Moderator: Watchareewan Sontichai

Optimal remission induction regimens for ANCA-associated vasculitis
Shunsuke Futura (F.E Asia)

Q&A with Shunsuke Futura (F.E Asia)



Moderator: Masayoshi Harigai

Human hepatitis virus infection and systemic vasculitides
Chrong-Reen Wang (F.E Asia)

Q&A with Chrong-Reen Wang (F.E Asia)


Update of monogenic vasculitis - DADA2 and VEXAS syndrome
Kowasr Asnaashari



Moderator: Aman Sharma

Q&A with Kosar Asnaashari


Closing comments
Masayoshi Harigai (F.E Asia)
Treatment advances in SLE and biomarkers

Chairpersons: Natalia Chu Oi Ciang and Yew Kuang Cheng

Quest for biomarkers in SLE: a round up in 2022
Chiam Putterman (Americas)

Treatment of SLE: advances and the Asian perspective
CC Mok (F.E Asia)

Role of kidney biopsy and choosing the right treatment in lupus nephritis
TM Chan (F.E Asia)

Q&A
1315-1455
Lunch symposium 1
Lunch symposium 2
Rapid fire poster presentations

Risk factors for moderate to severe COVID-19 infection in systemic lupus erythematosus
Wendell Espanola

Effectiveness of a pharmacist-led physician-supervised virtual monitoring clinic in achieving target serum urate in gout patients
He Jiang

Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study
Masaru Kato

Association of Baseline Characteristics with Minimal Disease Activity of Guselkumab Treatment in Biologic-Experienced PsA Patients: Phase IIIb COSMOS Clinical Trial
Masaru Kato

Humoral and Cellular Immunogenicity against SARS-CoV-2 mRNA Vaccine in Patients with Inflammatory Rheumatic Disease; Comparison of mRNA-1273 Vaccine and BNT162b2
Yasushi Kondo

Global glucocorticoid treatment patterns in patients with systemic lupus erythematosus: results of a systematic literature review
Eric Morand

The dysregulation of complement activation in the diffuse connective tissue diseases
Haijun Ma

Bimekizumab Improves Signs and Symptoms of Active Non-Radiographic Axial Spondyloarthritis: 24-Week Results from the Phase 3 BE MOBILE 1 Study
Huji Xu

Effects of antirheumatic drugs on prevalence and clinical outcome of COVID-19 in systemic lupus erythematosus: a meta-analysis
Qin-Yi Su

Fc gamma receptor polymorphism in SLE: Association with clinical phenotypes and disease severity
Sonalika Sahoo

Bone Microarchitecture Assessed by 3D High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) as predictor of fracture risk in patients with glucocorticoid-induced-osteoporosis
Ho So

Risk of autoimmune diseases in patients with Covid-19
James Cheng-chung Wei

The correlation of altered gut microbiome and expression of Tfr/Tfh cells in peripheral blood of new-onset patients with rheumatoid arthritis
Ruihe Wu

Low estimated glomerular filtration rate is an independent risk factor for hydroxychloroquine concentration
Xue Zhong
BREAK AND POSTER VIEWING
1455-1610
Updates in systemic sclerosis

Chairpersons: Andrea Low and Jasmin Raja

SSc and cancers
Kathleen Morrisroe (Oceania)

Updates on treatment of SSc associated gastrointestinal involvement
Jasmin Raja (S.E Asia)

Management of nutrition from a gastroenterologist's perspective
Ennaliza Salazar (S.E Asia)

Q&A

Challenging case of SSc
Dhaval Tanna (South Asia)
EULAR symposium: rheumatoid arthritis remission - from clinical definitions to imaging assessment. What is new?

Chairpersons: Yoshiya Tanaka and Lai Shan Tam

Remission in RA: is it a real remission?
Daniel Aletaha (Europe)

Imaging RA: what is new?
Annamaria Iagnocco (Europe)

Q&A
AYR Symposium: Rheumatology in the elderly

Chairpersons: Tanveer Hasan and Priscilla Wong

Age-related changes in the immune system and the consequences of immunosenescence
Elaine Au (F.E Asia)

Patterns of rheumatological diseases in older adults and key geriatrics concepts
Raymond Yung (Americas)

Geriatric rheumatology - time to establish a new subspecialty in elderly care
Himantha Atukorale (South Asia)

Q&A
Recent progress in treatments of SLE

Chairpersons: CC Mok and Kai Lai Lee

Voclosporin
Tatsuya Atsumi (F.E Asia)

Belimumab in SLE: milestones and learnings
Sandra Navarra (S.E Asia)

Interferon blockade in SLE - the evidence and the opportunity
Eric Morand (Oceania)

Baricitinub
Yoshiya Tanaka (F.E Asia)

Q&A
1610-1640
BREAK AND POSTER VIEWING
1640-1755
Immunology essentials for rheumatologists

Chairpersons: Philip Li and Asmah Mohd

Restoring balance in the immune system: safety of biologics in rheumatology patients
Matthew Buckland (UK)

Immunology cases mimicking common rheumatological disorders
Sofia Grigoriadou (UK)

DADA2 / autoinflammatory diseases
Aman Sharma (F.E Asia)

Q&A
New frontiers in Sjogren's syndrome

Chairpersons: Galymzhan Togizbayev and Vera Chan

Immunopathogenesis of SS
Liwei Lu (F.E Asia)

New therapeutics in SS
Francesco Ciccia (Europe)

Management of SS
Wan-fai Ng (UK)

Q&A
Emerging concepts in spondyloarthritis

Chairpersons: James Wei and Simon Stebbings

The gut and spondyloarthritis: emerging evidence and controversies
Dirk Elewaut (Europe)

Uveitis and spondyloarthritis: more than meets the eye
Muhammad Haroon (South Asia)

Treat-to-target in spondyloarthritis - data from the APLAR SpA registry
Lai Shan Tam (F.E Asia)

Q&A
Musculoskeletal ultrasound in rheumatology

Chairpersons: Stella Wong and Peter Mandl

Role of MSUS in rheumatology - where are we now
Annamaria Iagnocco (Europe)

US evaluation of ILD in autoimmune disease
Carmen Ho (F.E Asia)

Enthesopathy and enthesitis
Kei Ikeda (F.E Asia)

Q&A
1800-1900
Evening symposium 1
Evening symposium 2
Evening symposium 3
Evening symposium 4
1900-2230
Social night

Key

Acronyms
F.E Asia – Far East Asia
S.E Asia – South East Asia
UK – United Kingdom

0800-0900
Chronic inflammation and immunogenetics in RA

Chairpersons: Yan Kitty Kwok and Shereen Ch'ng

The evolution of the autoimmune response before development of RA
Rene Toes (Europe)

Immunogenetics of rheumatoid arthritis and way forward
Kazuhiko Yamamoto (F.E Asia)

Q&A
Abstract session

Chairpersons: Samuel Whittle and Mengtao Li

Age-related genes USP2 and ARG2 are involved in the reduction of immune cell infiltration in elderly patients with rheumatoid arthritis
Qi Cheng

Bioinformatics and system biology approach to identify the influences of COVID-19 on Primary Sjogren's syndrome patients
Sheng-Xiao Zhang

The inhibiting role of MerTK on Neutrophil Extracellular Traps (NETs) formation in systemic lupus erythematosus (SLE)
Ranran Yao

Autoantibodies Against Malondialdehyde-modifications Promote Osteoclast Development by Reprogramming Cellular Metabolism
Koji Sakuraba

Performance of Soluble CD28 as a Potential Marker of Systemic Lupus Erythematosus
Mirza Zaka Pratama

Metabolomics analysis identifies biomarkers for APS and suggests potential new pathway for APS pathogenesis
Yongjing Luo

The roles of iTr35 cells in the inflammatory response and fibrosis progression of systemic sclerosis
Ling Lei

MicroRNA-27a-3p inhibits lung and skin fibrosis of systemic sclerosis by negatively regulating SPP1
Qi Cheng
Abstract session

Chairpersons: Zhangguo Li and Prapaporn Pisitkun

Incidence and outcome of COVID-19 in AIRD patients on concomitant treatment with tofacitinib- results from KRA COVID COHORT (KRACC) subset
Pramod Chebbi

COVID-19 vaccine hesitancy and the effectiveness of vaccination education in Thai patients with systemic lupus erythematosus
Ajchara Koolvisoot

Using HScore for the evaluation of the signs of hemophagocytosis in multisystem inflammatory syndrome associated with COVID-19 in children
Mikhail Kostik

Vaccine hesitancy among patients with idiopathic inflammatory myopathies and rheumatic diseases patients in 2021-2022 COVAD study
Babur Salim

Long COVID-19 in autoimmune and rheumatic diseases: data from COVID-19 vaccination in autoimmune diseases study
Syahrul Sazliyana Shaharir

Comparison of risk factors during first and second wave of COVID-19 in patients with autoimmune rheumatic diseases (AIRD) results from KRACC subset
Vineeta Shobha

Long-term humoral response to SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases
David Simon

Identification of shared genes and possible therapeutic target between systemic lupus erythemotosus and COVID-19
Sheng-Xiao Zhang
0900-1030
Plenary session 2

Chairpersons: Debashish Danda and Ronald Yip

The AxSpA spectrum - using pathogenesis to apply therapeutic strategies?
Iain McInnes (UK)

2022 updates of RA treatment from Japanese experiences
Tsutomu Takeuchi (F.E Asia)

Osteoporosis 2022: Bones of contention
Kenneth Saag (Americas)
1030-1055
BREAK AND POSTER VIEWING
1055-1200
Morning symposium 5
Morning symposium 6
Morning symposium 7
Morning symposium 8
1200-1315
Controversies in IIM

Chairpersons: Ingrid Lundberg and Ho So

Is the diagnosis "polymyositis" obsolete?
Vidya Limaye (Oceania)

Myositis-specific autoantibody testing: who, when and how to measure?
Takahisa Gono (F.E Asia)

COVID-19 and myositis: friend or foe?
Latika Gupta (South Asia)

Q&A
Glucocorticoids in rheumatology - a never-ending story?!

Chairpersons: Frank Buttgereit and Debashish Danda

Glucocorticoids for the treatment of RA: past, present and future
Frank Buttgereit

Conventional glucocorticiod molecules versus deflazacort in rheumatology practice - a comparative overview
Debashish Danda

Current recommendations for the use of glucocorticoids in vasculitides and systemic lupus erythematosus
Sarfaraz A Hasni
A fresh look into the demographic, co-morbids, and management of gout

Chairpersons: Paulo Lorenzo and Helen Keen

The management of gout beyond pain and urate lowering therapy
Binit Vaidya (South Asia)

Young-onset gout; is the demographic changing?
Evelyn Salido (South Asia)

The treatment of gout and kidney disease
Chang-Nam Son (F.E Asia)

Developing a gout registry for APLAR
Kanon Jatuworapruk (S.E Asia)

Q&A
Exercise prescription and monitoring in the technology era

Chairpersons: Monika de Silva and Arnold Wong

Combating joint pain in ADL: what new technologies can help?
Serena Ng

How to prescribe exercise via on-line mode for knee osteoarthritis?
Rachel Nelligan (Oceania)

Can VR/AR motivate exercise participation for knee osteoarthritis
Amy Fu (F.E Asia)

Q&A
1315-1455
Lunch symposium 3
Lunch symposium 4
New IJRD services for the APLAR members

Chairpersons: James Cheng-Chung Wei and Chih-Wei Chen

Shaping IJRD to new future for health promotion
James Cheng-Chung Wei

New author guidelines of IJRD
Chih-Wei Chen

New submission services of IJRD
Alison Bell
BREAK AND POSTER VIEWING
1455-1610
What is the added value of imaging in the assessment of rheumatic diseases

Chairpersons: Kok Ooi Kong and Ho Yin CHung

MRI in axSpA: where are we now?
Ashish Jacob Matthew (South Asia)

Ultrasound in RA: where are we now?
Zhuo-li Zhang (F.E Asia)

Ultrasound in CTD: where are we now?
Kuo-Lung (F.E Asia)

Ultrasound in PsA: where are we now?
Gavin Lee (F.E Asia)
Using genetics to prioritize diagnoses for rheumatology outpatients with inflammatory arthritis

Chairpersons: Michael Tee and Leong Khai Pang

Genetic studies using machine intelligence and network analysis
Geoff Solano (South Asia)

G-PROB (Genetic Probability tool) - taking advantage of genetic risk scoring
Chikashi Terao (F.E Asia)

2022 key highlights in genetic and translational research
Michael Tee

Q&A
Updates in treatment of vasculitis

Chairpersons: Steve HT Pang and Catherine Hill

The efficacy and safety of Tocilizumab and Tofacitinib in the treatment of Takayasu’s arteritis:a real world study
Tian Xinping (F.E Asia)

Anti-neutrophil cytoplasmic antibody-associated vasculitis - oral or intravenous treatment?
Masayoshi Harigai (F.E Asia)

Behcet's disease in Asia Pacific - what is special?
Worawit Louthrenoo (S.E Asia)

Q&A
Human rights in the management of rheumatic disorders

Chairperson: Syed Atiqul Haq

Strengthening health systems to address musculoskeletal disability
Andrew Briggs (Oceania)

Patient outreach challenges and solutions
Nighat Mir Ahmad (South Asia)

Q&A
1610-1640
BREAK AND POSTER VIEWING
1640-1755
Multidisciplinary team management of rheumatic disease

Chairpersons: Mei Shun Cheung and Juan Javier T. Lichauco

Validation of the hospital anxiety and depression scale as a screening tool in Axial Spondyloarthritis patients
Cynthia Chan (F.E Asia)

Rheumatology nurse collaboration programme with pharmacists
Xanthe Chua (S.E Asia)

Rheumatology nurse consultations for patients with rheumatoid arthritis - an evidence based model in Asia Pacific
Kwok Suet Kei (F.E Asia)

Q&A
Ankylosing Spondylitis - from bench to bedside

Chairpersons: Jeiro Gu and Sami Salman

How does gut microbiome drive the pathogenesis of AS
Huji Xu (F.E Asia)

Ankylosing spondylitis: an autoimmune or autoinflammatory disease?
Francesco Ciccia (Europe)

Therapies for spondyloarthritis: past, present and future
Iain McInnes (UK)

Q&A
Novel disease and novel therapies

Chairpersons: Yi Liu and CW Yim

What do we need to know about VEXAS syndrome
Yohei Kirino (F.E Asia)

CAR-T cells - a new era of treating severe SLE
Georg Schett (Europe)

Stem cell transplantation in rheumatic diseases
Thomas Chan Sau Yan (F.E Asia)

Q&A
Difficult to treat myopathy

Chairperson: Jiuliang Zhao and Boonjing Siripaitoon

Difficult to treat myopathy
Ingrid Lundberg (Europe)

Novel biomarkers in IIM
Guochun Wang (F.E Asia)

Anti-MDA5 dermatomyositis
Ho So (F.E Asia)

Q&A
1800-1900
Evening symposium 5
Evening symposium 6
Evening symposium 7
Evening symposium 8
2000-2115
Holistic management of psoriatic arthritis - where are we now?


**This is a virtual only session - all attendees are required to join this session virtually**

Chairpersons: Muhammad Ahmed Saeed and Nazrul Islam


Collaborating with dermatology: practice beyond diagnosing
Kichul Shin (F.E Asia)

Inflammation and metabolic syndrome: lessons learnt from psoriatic disease
Muhammad Haroon (South Asia)

Composite measures for PsA outcomes
Katy Leung (S.E Asia)

Q&A
DC-VAS classification criteria for vasculitides

**This is a virtual only session - all attendees are required to join this session virtually**


Moderator: Boonjing Siripaitoon

DC-VAS classification criteria for microscopic polyangiitis and granulomatosis with polyangiitis
Ali Bin Sarwar Zubairi (South Asia)

Q&A with Ali Bin Sarwar Zubairi (South Asia)


Moderator: Boonjing Siripaitoon

DC-VAS classification criteria for EGPA
Jung Yoon Pyo (F.E Asia)

Q&A with Jung Yoon Pyo (F.E Asia)


Moderator: Galyn Togizbavey

DC-VAS classification criteria for giant cell arteritis
Anthony Michael Sammel (Oceania)

Q&A with Anthony Michael Sammel (Oceania)


Moderator: Galym Togizbavey


DC-VAS classification criteria for Takayasu arteritis
Alireza Khabbazi (Middle East)

Q&A with Alireza Khabbazi (Middle East)


Closing remarks
Debashish Danda (South Asia)
Back pain - a COPCORD community perspective


**This is a virtual only session - all attendees are required to join this session virtually**

Chairpersons: Arvind Chopra and Ashish Mathews

Introduction and field issues
Arvind Chopra

Aetiology and biomechanics
Ashish Mathews

Global burden of disease project
Maneula Ferreira

COPCORD Asia
Mohsen Soroush

Management strategy (Red & Yellow)
Samuel Whittle

Q&A


Conclusion and research agenda
Arvind Chopra
1930-2130
Presidential Dinner (by invitation only)

Key

Acronyms
F.E Asia – Far East Asia
S.E Asia – South East Asia
UK – United Kingdom

0800-0900
Abstract session

Chairpersons: Shirley Chan and B.G. Dharmanand

Rituximab shows superior efficacy above conventional non-biologics treatment in pediatric lupus nephritis: the preliminary data of retrospective cohort study
Mikhail Kostik

Incidence and factors associated with Chikungunya chronic arthritis after Chikungunya virus infection
Panchalee Satpanich

Influence of repetitive transcranial magnetic stimulation of CNS on fibromyalgia patients - a randomised, double blind, placebo-controlled study (interim analysis)
Zoran Velickovic

Efficacy and safety of bimekizumab in Chinese patients with active Ankylosing Spondylitis from the Phase 3 study BE MOBILE 2
Huji Xe

Social media use among spondyloarthritis experts: results of an online survey conducted among members of assessment of spondyloarthritis international society
Yu Heng Kwan

Clinical profile of 4 children with juvenile dermatomysoitis and anti-SAE antibody positivity: a single centre experience from North India
Prabal Barman

Dysbiosis of the gut microbiota in patients with psoriatic arthritis is closely related to lymphocyte subsets and cytokines
Sheng-Xiao Zhang

Analysis of gut microbiota compositions and their associations with peripheral lymphocyte subsets and cytokines in patients with Bechet's disease
Qin-Yi Su
Abstract session

Chairpersons: Mei Yan Clara Law and Chit Soe

Utilities of low-dose computed tomography (LDCT) in identifying patient with axial psoriatic arthritis (AxPsA) - a cross-sectional study
Isaac Tsz Ho Cheng

COVID-19 vaccination related short term adverse events in patients with idiopathic inflammatory myositis- and autoimmune multimorbidity: results from the COVAD survey
Lisa Traboco

The Gut Microbiota and its relevance to peripheral lymphocyte subpopulations and cytokines in patients with idiopathic inflammatory myopathies
Qin-Yi Shu

Analysis on clinical risk factors of hospitalisation of Asian CTD-PAH patients by the Markov Chain Model
Tsu-Yi Hsieh

Semiquantitative thigh magnectic resonance imaging (tMRI) in determining skeletal muscle outcomes at baseline and on follow-up in idiopathic inflammatory myopathies
Mamatha Gorijavolu

Male SpA patients with longer disease duration have less severe disc degeneration - a propensity-score matched comparison with the population
Tin Yan Samuel Cheung

Are we treating to target in spondyloarthritis (SpA)? a cross sectional analysis from the Asia Pacific League of Associations for Rheumatology (APLAR) SpA registry
Isaac Tsz Ho Cheng
Abstract session

Chairpersons: Nan Shen and Sumariyono

Physician burnout in rheumatology practitioners and fellows: a survey based cross-sectional study
Muhmmad Arqam Miraj

Memory CD4+T Cell signature is associated with unfavorable prognosis in IgG4-related disease: Risk Stratification by Machine-learning
Yuxue Nie

Transcriptomic perspective on peripheral megakaryocyte reduction in primary Sjogren's syndrome
Sheng-Xiao Zhang

The role of genes in systemic lupus erythematosus
Mikhail Kostik

LDIL2 synthesis with Belimumab in the treatment of Systemic Lupus Erythematosus patients
Ruiling Feng

Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks
James Cheng-chung Wei

Clinical characteristics and outcomes of primary immunodeficiency diseases complicated with autoimmune disorders: experience from a single tertiary center
Haojie Xu

Absolute decrease in circulating regulatory T cells is associated with adverse pregnancy outcome in patients with systemic lupus erythematosus
Sheng-Xiao Zhang
0900-1030
Plenary session 3

Chairpersons: Sang-heon Lee and Chi Hung To

Advances in the understanding and management of atherosclerosis in inflammatory arthritis
Lai Shan Tam (F.E Asia)

Infection and the pathogenesis of autoimmune rheumatic disease
Ranjeny Thomas (Oceania)

Imaging in RA
Annamaria Iagnocco (Europe)
1030-1055
BREAK AND POSTER VIEWING
1055-1210
Osteoporosis special interest group session

Chairpersons: Sumapa Chaiamnuay and Lau Tang Ching

Monitoring osteoporosis treatment - role of bone turnover markers
Sumapa Chaiamnuay (S.E Asia)

Reliability or limitation of FRAX as risk assessment tool
Lau Tang Ching (S.E Asia)

Bone Density in Chronic Kidney Disease
Julie Yu (S.E Asia)

Q&A
Genetics and resources: impact on outcome of childhood rheumatic diseases session 2

Chairpersons: Surjit Singh and Caifeng Li

Introduction
Surjit Singh and Caifeng Li

Paediatric rheumatology SIG webinars: an update
Elizabeth Ang (S.E Asia)

Managing difficult lupus in developing LI/MI countries
Christine Bernal (S.E Asia)

Juvenile arthritis management inless resourced countries: expanding on JAMless
Chris Scott (Africas)

Genetic research initiatives in developing countries
Laura Lewandowski (Americas)

Q&A

Closing remarks
Sumaira Farman (South Asia)
OA is relevant

Chairpersons: Keith Lim and Carrel Yu

Update on therapy: PRP injections: Do they work?
Kade Paterson (Oceania)

Joint replacement surgery of the lower limb in OA in Malaysia
David Choon (S.E Asia)

Research project from APLAR
Matthew Jiang (Oceania) and Ester Penserga
Rheumatoid arthritis special interest group session

Chairpersons: Kunihiro Yamaoka and Zhanguo Li

Butrate-metabolizing specie contribute to clinical features and bone erosion in rheumatoid arthritis
Yu Kang (F.E Asia)

Recent advances in treatment of rheumatoid arthritis
Jon Giles (Americas)
1210-1350
Lunch symposium 5
Lunch symposium 6
BREAK AND POSTER VIEWING
1350-1505
Clinical guidelines in paediatric rheumatology

Chairpersons: Assunta Ho

Juvenile systemic erythematosus - update and consensus recommendations
Thaschawee Arkachaisri (S.E Asia)

Juvenile systemic sclerosis - update and consensus recommendations
Ivan Foeldvari (Europe)

Pediatric rheumatic disease - the transition to adults
Sumaira Farman (South Asia)

Q&A
Advances in systemic sclerosis

Chairpersons: Jonathan Au and Mandana Nikpour

Disease activity measurement and outcome predictors in systemic sclerosis
Masataka Kuwana (F.E Asia)

Systemic sclerosis-associated pulmonary arterial hypertension
Susanna Proudman (Oceania)

Biomarkers in systemic sclerosis
Dinesh Khanna (Americas)

Q&A
Combined SIG Business Meeting

**Meeting commences at 1240 hours

Introduction
Debashish Danda

APLAR Academy update
Lai-Shan Tam

Crystal-induced arthritis SIG update
Jose Paulo Lorenzo

Epidemiology SIG update
Arvind Chopra

AYR update
Priscilla Wong

Paediatric SIG update
Sumaira Farman

Scleroderma SIG update
Andrea Low

Social commitment and patient outreach SIG update
Syed Atiqul Haq

SLE SIG update
Yoshiya Tanaka

Vasculitis SIG update
Debasish Danda

Conclusion
Debashish Danda
Artificial intelligence in rheumatology

Chairpersons: Hideto Kameda and Moon Ho Alexander Leung

How A.I. can be applied in RA Management
Ernest Choy (UK)

MRI in subclinical inflammation for patients with arthralgia
Annette van der-Helm van mil (Europe)

Classification of seropositive RA, seronegative RA, and PsA in MRI using neural networks
Lukas Folle

Developing artificial intelligence model for skin thickness assessment in systemic sclerosis
Patnarin Pongkulkiat

Electronic health record based deep learning model for predicting disease activity in patients with rheumatoid arthritis
Zelin Yun

Q&A
1505 - 1535
Closing Ceremony
Translate »